Author Correction: SGLT2 inhibitors reduce the risk of renal failure in CKD stage 5 patients with Type 2 DM. - Huang B; Yen CL; Wu CY; Tsai CY; Chen JJ; Hsiao CC; Chen YC; Hsieh IC; Yang HY (Scientific reports, 2025)